Gene delivery to carcinoma cells via novel non-viral vectors: Nanoparticle tracking analysis and suicide gene therapy

European Journal of Pharmaceutical Sciences

Volumn 60, Issue , 2014, Pages 72-79

  Gebremedhin, Senait ^a   Singh, Aruna ^a   Koons, Stephen ^a   Bernt, William ^b   Konopka, Krystyna ^a   Duzgunes, Nejat ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b Particle Characterization Laboratories   (United States)

Author keywords

Cancer gene therapy; Cervical cancer; FuGENE HD; Metafectene Easy; Nanoparticle tracking analysis; Oral cancer

Indexed keywords

BETA GALACTOSIDASE; FUGENE HD; GANCICLOVIR; GLYCOFECT; LUCIFERASE; METAFECTENE; METAFECTENE EASY; METAFECTENE PRO; NON VIRAL VECTOR; PLASMID DNA; SITIMAGENE CERADENOVEC; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS VECTOR; ANTIVIRUS AGENT; DNA; NANOPARTICLE;

ANALYSIS; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL LINE; HERPES SIMPLEX VIRUS; HSC 3 CELL LINE; HUMAN; HUMAN CELL; MOUTH SQUAMOUS CELL CARCINOMA; NANOPARTICLE TRACKING ANALYSIS; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE THERAPY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; PLASMID; PROCEDURES; SIMPLEXVIRUS; SQUAMOUS CELL CARCINOMA; SUICIDE TRANSGENE; TUMOR CELL LINE;

ANTIVIRAL AGENTS; BETA-GALACTOSIDASE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DNA; GANCICLOVIR; GENES, TRANSGENIC, SUICIDE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LUCIFERASES; NANOPARTICLES; PLASMIDS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION;

EID: 84901943253     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2014.03.003     Document Type: Article

References (29)

1. W.M. Abuzeid, D. Li, and B.W. O'Malley Jr. Gene therapy for head and neck cancer Adv. Otorhinolaryngol. 70 2011 141 151
2. A. Amalfitano, and R.J. Parks Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy Curr. Gene Ther. 2 2002 111 133
3. M.S. Dilber, and G. Gahrton Suicide gene therapy: possible applications in haematopoietic disorders J. Int. Med. 249 2001 359 367 (Pubitemid 34293783)
4. S. Duarte, G. Carle, H. Faneca, M.C. Pedroso de Lima, and V. Pierrefite-Carle Suicide gene therapy in cancer: where do we stand now? Cancer Lett. 324 2012 160 170
5. N. Duzgunes, S. Simões, P. Pires, and M.C. Pedroso de Lima Gene delivery by cationic liposome-DNA complexes S. Dumitriu, Polymeric Biomaterials 2001 Marcel Dekker New York 943 958
6. S. Gao, E. Seker, M. Casali, F. Wang, S.S. Bale, G.M. Price, and M.L. Yarmush Ex vivo gene delivery to hepatocytes: techniques, challenges, and underlying mechanisms Ann. Biomed. Eng. 40 2012 1851 1861
7. K. Konopka, E. Pretzer, P.L. Felgner, and N. Duzgunes Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes Biochim. Biophys. Acta 1312 1996 186 196 (Pubitemid 26246516)
8. K. Konopka, A. Lee, N. Moser-Kim, S. Saghezchi, A. Kim, A. Lim, V.V. Suzara, and N. Duzgunes Gene transfer to human oral cancer cells via nonviral vectors and HSV-tk/ganciclovir-mediated cytotoxicity: potential for suicide gene therapy Gene Ther. Mol. Biol. 8 2004 307 318
9. K. Konopka, B. Fallah, J. Monzon-Duller, N. Overlid, A. Lim, and N. Duzgunes Serum-resistant gene transfer to oral cancer cells by Metafectene and Genejammer: application to HSV-tk/ganciclovir-mediated cytotoxicity Cell. Mol. Biol. Lett. 10 2005 455 470 (Pubitemid 41564518)
10. C. Lavorini-Doyle, S. Gebremedhin, K. Konopka, and N. Duzgunes Gene delivery to oral cancer cells by nonviral vectors: why some cells are resistant to transfection J. Calif. Dent. Assoc. 37 2009 855 858
11. D. Li, J.W. Zeiders, S. Liu, M. Guo, Y. Xu, J.S. Bishop, and B.W. O'Malley Jr. Combination nonviral cytokine gene therapy for head and neck cancer Laryngoscope 111 2001 815 820 (Pubitemid 32422774)
12. Lim, G.; Gebremedhin, S.; Ouellette, J.; Ulasov, I.; Lesniak, M.; Konopka, K.; Duzgunes, N.; 2010. Cationic liposome enhancement of adenoviral vectors for gene delivery to OSCC. J. Dent. Res. 89 (Special issue A) Abst. No. 1134, Seq. #141.
13. S.J. Murphy Viral delivery systems for gene therapy N.R. Lemoine, Understanding Gene Therapy 1999 Bios Scientific Publishers Oxford 21 42
14. S.S. Neves, H. Faneca, S. Bertin, K. Konopka, N. Duzgunes, V. Pierrefite-Carle, S.P. Simões, and M.C. Pedroso de Lima Transferrin-lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response Cancer Gene Ther. 16 2009 91 101
15. P. Orth, A. Weimer, G. Kaul, D. Kohn, M. Cucchiarini, and H. Madry Analysis of novel nonviral gene transfer systems for gene delivery to cells of the musculoskeletal system Mol. Biotechnol. 38 2008 137 144
16. J.S. Park, S. Surendran, L.M. Kamendulis, and N. Morral Comparative nucleic acid transfection efficacy in primary hepatocytes for gene silencing and functional studies BMC Res. Notes 4 2011 8
17. D. Portsmouth, J. Hlavaty, and M. Renner Suicide genes for cancer therapy Mol. Aspects Med. 28 2007 4 41
18. T.R. Saraswathi, B. Kavitha, and J.V. Priyadharsini Gene therapy for oral squamous cell carcinoma: an overview Ind. J. Dent. Res. 18 2007 120 123
19. S. Simões, P. Pires, N. Duzgunes, and M.C. Pedroso de Lima Cationic liposomes as gene transfer vectors: barriers to successful application in gene therapy Curr. Opin. Mol. Therapeut. 1 1999 147 157 (Pubitemid 29238420)
20. A.B. Sonia, C.T. Julián, C.S. Jorge, A.G. Miguel, E.C. Nayra, and B.M. Antonio Gene therapy in the management of oral cancer: review of the literature Med. Oral. Patol. Oral Cir. Bucal. 13 2008 E15 E21
21. J. Sudbø, and A. Reith The evolution of predictive oncology and molecular-based therapy for oral cancer prevention Int. J. Cancer. 115 2005 339 345 (Pubitemid 40663735)
22. C. Tros de Ilarduya, Y. Sun, and N. Duzgunes Gene delivery by lipoplexes and polyplexes Eur. J. Pharm. Sci. 40 2010 159 170
23. T. Wang, J.R. Upponi, and V.P. Torchilin Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies Int. J. Pharm. 427 2012 3 20
24. M. Wright Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions Methods Mol. Biol. 906 2011 511 524
25. S. Xi, and J.R. Grandis Gene therapy for the treatment of oral squamous cell carcinoma J. Dent. Res. 82 2003 11 16
26. M.E. Yalvaç, M. Ramazanoglu, O.Z. Gumru, F. Sahin, A. Palotás, and A.A. Rizvanov Comparison and optimisation of transfection of human dental follicle cells, a novel source of stem cells, with different chemical methods and electro-poration Neurochem. Res. 34 2009 1272 1277
27. S. Yamano, J. Dai, and A.M. Moursi Comparison of transfection efficiency of nonviral gene transfer reagents Mol. Biotechnol. 46 2010 287 300
28. X.X. Zhang, T.J. McIntosh, and M.W. Grinstaff Functional lipids and lipoplexes for improved gene delivery Biochimie 94 2012 42 58
29. I.S. Zuhorn, J.B. Engberts, and D. Hoekstra Gene delivery by cationic lipid vectors: overcoming cellular barriers Eur. Biophys. J. 36 2007 349 362 (Pubitemid 46626209)